Axogen, Inc. Reports 2018 Fourth Quarter and Full Year 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Axogen, Inc. Reports 2018 Fourth Quarter and Full Year 2018 Financial Results

AxoGen, Inc. (AXGN) PT Lowered to $35 at Jefferies

February 27, 2019 9:05 AM EST

Jefferies analyst Raj Denhoy lowered the price target on AxoGen, Inc. (NASDAQ: AXGN) to $35.00 (from $45.00) while maintaining a Buy rating.

... More

AxoGen (AXGN) Misses Q4 EPS by 4c

February 26, 2019 4:04 PM EST

AxoGen (NASDAQ: AXGN) reported Q4 EPS of ($0.09), $0.04 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $23.4 million versus the consensus estimate of $23.79 million.

We continue to see momentum in our core trauma, oral and maxillofacial, and breast reconstruction neurotization markets,... More